CNMD: CONMED Corporation Stock

by  •  • Comments Off on CNMD: CONMED Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 2,188.64
Enterprise Value ($M) 3,206.45
Book Value ($M) 796.21
Book Value / Share 25.86
Price / Book 2.75
NCAV ($M) -850.15
NCAV / Share -27.61
Price / NCAV -2.57

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 0.96
Current Ratio 1.98

Balance Sheet (mrq) ($M)
Current Assets 615.65
Assets 2,300.02
Liabilities 1,465.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,244.74
Operating Income 131.16
Net Income 64.46
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 125.35
Cash from Investing -20.03
Cash from Financing -110.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 11.12 -0.10
02-12 13G/A Earnest Partners Llc 7.60 -2.36
02-09 13G/A Capital Research Global Investors 9.00 25.76
01-22 13G/A BlackRock Inc. 16.40 2.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K United States Securities and Exchange Commission Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
2023-07-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
2023-04-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 58,000 381,919 15.19
2024-04-18 79,475 622,688 12.76
2024-04-17 82,325 938,187 8.77
2024-04-16 74,668 635,535 11.75
2024-04-15 71,481 611,446 11.69

(click for more detail)

Similar Companies
BLUA.U – BlueRiver Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-third of a BSX – Boston Scientific Corporation
CDRE – Cadre Holdings, Inc. ENOV – Enovis Corporation
EW – Edwards Lifesciences Corporation


Financial data and stock pages provided by
Fintel.io